文献速递肿瘤 PET/CT神经核医学

半自动肿瘤勾画评估64Cu-DOTATATE PET/CT在神经内分泌肿瘤中的预后价值:基于最低病灶摄取与总肿瘤体积

Semiautomatic Tumor Delineation for Evaluation of 64Cu-DOTATATE PET/CT in Patients with Neuroendocrine Neoplasms: Prognostication Based on Lowest Lesion Uptake and Total Tumor Volume.
PubMed 文献 · J Nucl Med · 2021-02-26

本研究在116例神经内分泌肿瘤患者中开发标准化半自动肿瘤勾画方法,识别64Cu-DOTATATE摄取最低的病灶并计算总肿瘤体积,发现最低SUVmean和总肿瘤体积与PFS和OS独立相关,而SUVmax仅与PFS相关,联合两者可构建新的预后分类系统。

要点

  • 半自动勾画可识别摄取最低病灶并计算总肿瘤体积。
  • 最低SUVmean和总肿瘤体积是PFS和OS的独立预后因素。
  • 低肿瘤体积且高最低SUVmean患者预后最佳。

核心结论

  • 评估最低而非最高病灶摄取可大幅提升64Cu-DOTATATE PET/CT的预后判断能力。
  • 联合病灶摄取与总肿瘤体积可构建神经内分泌肿瘤的新预后分类系统。

研究设计与样本

  • 回顾性分析116例神经内分泌肿瘤患者的64Cu-DOTATATE PET/CT。
  • 开发标准化半自动肿瘤勾画方法识别最低SUVmean病灶并计算总肿瘤体积。
  • 采用Kaplan-Meier和Cox回归分析评估与OS和PFS的关联。

主要发现

  • 116例患者中位PFS为23个月(95%CI 20-31个月),中位OS为85个月(95%CI 68-113个月)。
  • 单因素Cox分析中最低SUVmean和总肿瘤体积与PFS和OS均显著相关,SUVmax仅与PFS显著相关。
  • 多因素Cox分析中最低SUVmean和总肿瘤体积仍具统计学显著性。
  • 以中位数二分后,低总肿瘤体积且高最低SUVmean组对比高总肿瘤体积且低最低SUVmean组,PFS的HR为0.32(95%CI 0.20-0.51),OS的HR为0.24(95%CI 0.13-0.43),P值均小于0.001。

关键数值与推荐

  • 最低SUVmean定义为半自动勾画所识别摄取最低病灶的SUVmean。
  • 总肿瘤体积由半自动肿瘤勾画得出。
  • 最低SUVmean和总肿瘤体积按各自中位数二分,将患者分为4组。

临床怎么用

  • 在神经内分泌肿瘤的64Cu-DOTATATE PET/CT评估中,除最大摄取外应关注最低摄取病灶。
  • 结合最低病灶SUVmean与总肿瘤体积进行风险分层,辅助预后判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Patients with neuroendocrine neoplasms (NENs) have heterogeneous somatostatin receptor expression, with highly differentiated lesions having higher expression. Receptor expression of the total tumor burden may be visualized by somatostatin receptor imaging, such as with 64Cu-DOTATATE PET/CT. Assessment of maximal lesion uptake is associated with progression-free survival (PFS) but not overall survival (OS). We hypothesized that the lesion with the lowest, rather than the highest, 64Cu-DOTATATE uptake would be more prognostic, and we developed a semiautomatic method for evaluating this hypothesis. Methods: Patients with NENs underwent 64Cu-DOTATATE PET/CT. A standardized semiautomatic tumor delineation method was developed and used to identify the lesion with the lowest uptake, that is, with the lowest SUVmean Additionally, we assessed total tumor volume derived from the semiautomatic tumor delineation. Kaplan-Meier and Cox regression analyses were used to determine whether there was any association with OS and PFS. Results: In 116 patients with NENs, median PFS (95% CI) was 23 mo (range, 20-31 mo) and median OS was 85 mo (range, 68-113 mo). Minimum SUVmean and total tumor volume were significantly associated with PFS and OS in univariate Cox regression analyses, whereas SUVmax was significant only for PFS. In multivariate Cox analyses, both minimum SUVmean and total tumor volume remained statistically significant. Minimum SUVmean and total tumor volume were then dichotomized by their median, and patients were categorized into 4 groups: high or low total tumor volume and high or low minimum SUVmean Patients with a low total tumor volume and high minimum SUVmean had a hazard ratio of 0.32 (95% CI, 0.20-0.51) for PFS and 0.24 (95% CI, 0.13-0.43) for OS, both with P values of less than 0.001 (reference: high total tumor volume and low minimum SUVmean). Conclusion: We propose a standardized semiautomatic tumor delineation method to identify the lesion with the lowest 64Cu-DOTATATE uptake and total tumor volume. Assessment of the lowest, rather than the highest, lesion uptake greatly increases prognostication by 64Cu-DOTATATE PET/CT. Combining lesion uptake and total tumor volume, we derived a novel prognostic classification system for patients with NENs.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Carlsen EA, Johnbeck CB, Loft M, et al. Semiautomatic Tumor Delineation for Evaluation of 64Cu-DOTATATE PET/CT in Patients with Neuroendocrine Neoplasms: Prognostication Based on Lowest Lesion Uptake and Total Tumor Volume. J Nucl Med. 2021. PMID: 33637589. doi:10.2967/jnumed.120.258392

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。